Marty Makary resigned as FDA commissioner amid controversy. But his reforms to drug review times and AI are the agency's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results